Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-11 Sale | 2022-05-13 4:37 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $41.9 | $222,050 | 151,805 (Direct) | View |
| 2022-04-11 Sale | 2022-04-13 4:36 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $62.77 | $332,705 | 157,105 (Direct) | View |
| 2022-04-06 Sale | 2022-04-08 4:21 pm | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 1,728 | $65 | $112,320 | 8,002 (Direct) | View |
| 2022-04-04 Sale | 2022-04-06 4:49 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 7,950 | $60 | $477,000 | 162,405 (Direct) | View |
| 2022-04-01 Sale | 2022-04-05 4:31 pm | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 864 | $57.49 | $49,675 | 9,730 (Direct) | View |
| 2022-03-11 Sale | 2022-03-15 4:37 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $53.38 | $141,449 | 170,355 (Direct) | View |
| 2022-02-11 Sale | 2022-02-15 4:26 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $52.06 | $137,965 | 173,005 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 4:39 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $53.75 | $142,447 | 175,655 (Direct) | View |
| 2022-01-05 Sale | 2022-01-07 4:35 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $60 | $159,000 | 178,305 (Direct) | View |
| 2022-01-03 Sale | 2022-01-05 7:14 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 47,651 | $57.84 | $2,756,116 | 232,727 (Indirect) | View |
| 2021-12-13 Sale | 2021-12-15 4:48 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $50.4 | $133,558 | 276,945 (Direct) | View |
| 2021-12-01 Sale | 2021-12-03 5:05 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 47,651 | $54.09 | $2,577,376 | 251,536 (Indirect) | View |
| 2021-11-10 Sale | 2021-11-12 4:40 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 21,200 | $59.91 | $1,270,058 | 286,810 (Direct) | View |
| 2021-11-04 Sale | 2021-11-05 5:06 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 10,600 | $50 | $530,000 | 204,805 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 7:04 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 47,651 | $42.12 | $2,007,129 | 270,346 (Indirect) | View |
| 2021-10-19 Sale | 2021-10-21 4:29 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 8,598 | $38.2 | $328,441 | 289,156 (Indirect) | View |
| 2021-10-14 Sale | 2021-10-18 8:35 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 26,367 | $38.56 | $1,016,653 | 292,550 (Indirect) | View |
| 2021-10-01 Sale | 2021-10-05 8:47 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 12,686 | $40.1 | $508,755 | 302,958 (Indirect) | View |
| 2021-09-27 Sale | 2021-09-29 4:39 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 95,302 | $41.17 | $3,924,003 | 307,966 (Indirect) | View |
| 2021-07-01 Sale | 2021-07-06 6:02 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 47,652 | $41.31 | $1,968,352 | 345,585 (Indirect) | View |
| 2021-06-11 Sale | 2021-06-15 5:02 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $50.98 | $135,087 | 207,612 (Direct) | View |
| 2021-06-11 Sale | 2021-06-15 5:01 pm | Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer | 1,000 | $50.99 | $50,990 | 98,211 (Direct) | View |
| 2021-06-04 Sale | 2021-06-08 4:31 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 19,415 | $49.07 | $952,613 | 364,395 (Indirect) | View |
| 2021-06-01 Sale | 2021-06-03 8:06 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 28,236 | $49.71 | $1,403,553 | 372,059 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-11 Exercise | 2022-05-13 4:37 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0.3 | 151,805 (Direct) | View |
| 2022-05-11 Exercise | 2022-05-13 4:37 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0 | 151,805 (Direct) | View |
| 2022-04-11 Exercise | 2022-04-13 4:36 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0.3 | 157,105 (Direct) | View |
| 2022-04-11 Exercise | 2022-04-13 4:36 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0 | 157,105 (Direct) | View |
| 2022-04-06 Exercise | 2022-04-08 4:21 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 1,728 | $16 | 8,002 (Direct) | View |
| 2022-04-06 Exercise | 2022-04-08 4:21 pm | N/A 2030-04-07 | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 1,728 | $0 | 8,002 (Direct) | View |
| 2022-04-04 Exercise | 2022-04-06 4:49 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 7,950 | $0.3 | 162,405 (Direct) | View |
| 2022-04-04 Exercise | 2022-04-06 4:49 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 7,950 | $0 | 162,405 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-05 4:31 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 864 | $16 | 9,730 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-05 4:31 pm | N/A 2030-04-07 | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 864 | $0 | 9,730 (Direct) | View |
| 2022-03-11 Exercise | 2022-03-15 4:37 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0.3 | 170,355 (Direct) | View |
| 2022-03-11 Exercise | 2022-03-15 4:37 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0 | 170,355 (Direct) | View |
| 2022-02-11 Exercise | 2022-02-15 4:26 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0.3 | 173,005 (Direct) | View |
| 2022-02-11 Exercise | 2022-02-15 4:26 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0 | 173,005 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:45 pm | N/A 2032-01-31 | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-02-01 Ownership | 2022-02-03 4:37 pm | N/A 2029-09-18 | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 0 | $0 | 32,898 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 4:17 pm | N/A 2032-01-20 | Keros Therapeutics Inc. | KROS | Seehra Jasbir CEO | 165,000 | $0 | 165,000 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 4:15 pm | N/A 2032-01-20 | Keros Therapeutics Inc. | KROS | Regnante Keith CFO | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 4:14 pm | N/A 2032-01-20 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 4:12 pm | N/A 2032-01-20 | Keros Therapeutics Inc. | KROS | Cooper Simon Peter Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-01-11 Exercise | 2022-01-13 4:39 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0.3 | 175,655 (Direct) | View |
| 2022-01-11 Exercise | 2022-01-13 4:39 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0 | 175,655 (Direct) | View |
| 2022-01-05 Exercise | 2022-01-07 4:35 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0.3 | 178,305 (Direct) | View |
| 2022-01-05 Exercise | 2022-01-07 4:35 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0 | 178,305 (Direct) | View |
| 2021-12-13 Exercise | 2021-12-15 4:48 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0.3 | 276,945 (Direct) | View |
| 2021-12-13 Exercise | 2021-12-15 4:48 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0 | 276,945 (Direct) | View |
| 2021-11-10 Exercise | 2021-11-12 4:40 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 21,200 | $0.3 | 286,810 (Direct) | View |
| 2021-11-10 Exercise | 2021-11-12 4:40 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 21,200 | $0 | 286,810 (Direct) | View |
| 2021-11-04 Exercise | 2021-11-05 5:06 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 10,600 | $0.3 | 204,805 (Direct) | View |
| 2021-11-04 Exercise | 2021-11-05 5:06 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 10,600 | $0 | 204,805 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-18 5:21 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 1,293 | $0.3 | 85,700 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-18 5:21 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 1,293 | $0 | 85,700 (Direct) | View |
| 2021-08-10 Option Award | 2021-08-11 4:56 pm | N/A 2031-08-09 | Keros Therapeutics Inc. | KROS | Cooper Simon Peter Chief Medical Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-06-24 Exercise | 2021-06-25 6:29 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 6,500 | $0.3 | 85,700 (Direct) | View |
| 2021-06-24 Exercise | 2021-06-25 6:29 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 6,500 | $0 | 85,700 (Direct) | View |
| 2021-06-11 Exercise | 2021-06-15 5:02 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0.3 | 207,612 (Direct) | View |
| 2021-06-11 Exercise | 2021-06-15 5:02 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0 | 207,612 (Direct) | View |
| 2021-06-11 Exercise | 2021-06-15 5:01 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer | 1,000 | $0.48 | 98,211 (Direct) | View |
| 2021-06-11 Exercise | 2021-06-15 5:01 pm | N/A 2029-09-18 | Keros Therapeutics Inc. | KROS | Ordonez Claudia Chief Medical Officer | 1,000 | $0 | 98,211 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:34 pm | N/A 2031-05-31 | Keros Therapeutics Inc. | KROS | Nussbaum Ran Director 10% Owner | 8,293 | $0 | 8,293 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:33 pm | N/A 2031-05-31 | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 8,293 | $0 | 8,293 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:31 pm | N/A 2031-05-31 | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 8,293 | $0 | 8,293 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:30 pm | N/A 2031-05-31 | Keros Therapeutics Inc. | KROS | GRAY MARY ANN Director | 8,293 | $0 | 8,293 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:29 pm | N/A 2031-05-31 | Keros Therapeutics Inc. | KROS | Farzan Nima Director | 8,293 | $0 | 8,293 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:27 pm | N/A 2031-05-31 | Keros Therapeutics Inc. | KROS | GORDON CARL L Director | 8,293 | $0 | 8,293 (Direct) | View |